Podcast: fighting counterfeits in Latin America and Caribbean

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Podcast: fighting counterfeits in Latin America and Caribbean

From left: Virginia Cervieri at Cervieri Monsuárez (Uruguay), André Oliveira at Daniel Law (Brazil) and Mikhail Jackson at Livingston Alexander & Levy (Jamaica)

Virginia Cervieri (Uruguay), André Oliveira (Brazil) and Mikhail Jackson (Jamaica) reveal their strategies for budget management, destruction and e-commerce




To listen to the full podcast, which is around one hour long, click the link above.

In Managing IP’s first LATAM and Caribbean podcast, Americas editor Patrick Wingrove speaks to Virginia Cervieri, co-founder at Cervieri Monsuárez in Uruguay, André Oliveira, partner at Daniel Law in Brazil, and Mikhail Jackson, partner at Livingston Alexander & Levy in Jamaica, about anti-counterfeiting.

Here, Cervieri, Oliveira and Jackson delve into anti-counterfeiting tactics and challenges surrounding budget management, destruction of fake products and e-commerce in their respective jurisdictions, and how those affect the rest of Latin America and the Caribbean.

more from across site and SHARED ros bottom lb

More from across our site

Julia Bishop is director of IP at Twilio in the US
Hellberg is an IP director at Essity in Sweden
Palińska is the business & IP law lead at CD Projekt Red in Poland
Teemu Itälä is head of legal and compliance for technology standards at Nokia in Finland
David Degen is senior IP counsel at Novartis, Switzerland
Demetrio Roberto Cavicchia is an IP director at Angelini Pharma in Italy
Schwitulla is the head of litigation management at Nokia in Germany
Almeida is the IP group leader at Bosch in Brazil
Amanda Luz is brand protection manager - global at Adidas in the US
Samantak Ghosh is vice president of IP at Avere Therapeutics in the US
Gift this article